RAD  Biomed  Incubator The Israeli incubator program  started in 1991 to provide a sheltered environment for scientists an...
9 Incubator companies The RAD Biomed Portfolio A RIO   M EDICA T ouch M ed TissueDetect Drug-delivery pump Gene therapy Pe...
Our Philosophy <ul><li>RBM is a biotech incubator that serves as a  natural interface between  the world of Israeli academ...
The  Deal Flow <ul><li>Projects are admitted to RBM either as a concept or as a small team with molecule/technology  & exe...
Rad BioMed Functions as a mini Pre-Seed VC <ul><li>Test Criteria   </li></ul><ul><li>Clinical   Need </li></ul><ul><li>Tea...
<ul><li>Our Nurturing Approach: </li></ul><ul><ul><li>Mapping  the needs (to reach the long-term goal),  Assessing  all   ...
Nurturing The People   <ul><li>In an ideal world, the “unskilled” entrepreneur  would step aside and make room for a “seas...
Funding <ul><li>RBM  incubator is owned and funded by the </li></ul><ul><li>Chairman of the RAD Group of Companies  </li><...
Task Oriented Management Team Idan Tamir, Ph.D. President  &   CEO Binah Baum, Ph.D. MBA Director, Business Dev Shoshi Key...
Handling The Maturing Company Building  Value To The Next Level √   Demonstrating proof of concept – critical milestone √ ...
Weaknesses <ul><li>Is project funding sufficient for required tasks? </li></ul><ul><li>will the tight budget allow us to c...
<ul><li>Go Europe: </li></ul><ul><li>create alliances </li></ul><ul><li>Inclusion of our SMEs in FP7 consortia </li></ul><...
Upcoming SlideShare
Loading in …5
×

Rad Biomed Incubator Heraklion Final

476 views

Published on

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
476
On SlideShare
0
From Embeds
0
Number of Embeds
30
Actions
Shares
0
Downloads
13
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Rad Biomed Incubator Heraklion Final

  1. 2. RAD Biomed Incubator The Israeli incubator program started in 1991 to provide a sheltered environment for scientists and entrepreneurs from the former USSR RBM was established in 1992 as general incubator, refocused in 1998 to biotech Located in Tel-Aviv Owned by the RAD group of companies Six active graduate companies InnoScent Ltd MaimoniDex RA
  2. 3. 9 Incubator companies The RAD Biomed Portfolio A RIO M EDICA T ouch M ed TissueDetect Drug-delivery pump Gene therapy Peripheral atherectomy Improved enzymes Molecular diagnostics Cord-blood harvesting Endoscopy Epidural-space detection Occu Pharma Opthalmic drug-delivery
  3. 4. Our Philosophy <ul><li>RBM is a biotech incubator that serves as a natural interface between the world of Israeli academic research and the global biotech industry </li></ul><ul><li>Long term vision : to build viable businesses and to create sustainable benefits to the economy and a significant return to investors and to the entrepreneurs </li></ul><ul><li>The goal of the incubation period is to prove the technological concept and its  feasibility and to advance it towards commercialization. </li></ul>To attain our goal we establish for each project a business model & strong IP position, and demonstrate that it  can attain profitability in a targeted market segment
  4. 5. The Deal Flow <ul><li>Projects are admitted to RBM either as a concept or as a small team with molecule/technology & executive-summary/IP/work-plan etc. </li></ul><ul><li>Deal flow is generated in the following manner: </li></ul><ul><ul><li>Entrepreneurs approach the incubator </li></ul></ul><ul><ul><li>Via our working relationship with TTOs </li></ul></ul><ul><li>Proactive search for projects in Israeli academia and hospitals </li></ul><ul><ul><li>Personal contacts </li></ul></ul>
  5. 6. Rad BioMed Functions as a mini Pre-Seed VC <ul><li>Test Criteria </li></ul><ul><li>Clinical Need </li></ul><ul><li>Team </li></ul><ul><li>Market </li></ul><ul><li>IP </li></ul><ul><li>Technology </li></ul><ul><li>Project status </li></ul>RAD BioMed’s Investment Committee Proactive search for projects Approval Product Positioning Incoming deal- flow Screening the deal-Flow
  6. 7. <ul><li>Our Nurturing Approach: </li></ul><ul><ul><li>Mapping the needs (to reach the long-term goal), Assessing all the available resources at set-up, Implementing and supporting </li></ul></ul>Nurturing T he Young Project While keeping our focus on the startup’s long term goals, we build the company’s work-plan & activities step-by-step to position it for the next round of financing <ul><li>RBM provides the incubator projects : </li></ul><ul><li>Management & legal and financial support </li></ul><ul><li>Business development and clinical consulting </li></ul><ul><li>IP strategy and regulatory & reimbursement planning </li></ul><ul><li>Extensive lab space for R & D </li></ul>
  7. 8. Nurturing The People <ul><li>In an ideal world, the “unskilled” entrepreneur would step aside and make room for a “seasoned” business-oriented project-leader </li></ul><ul><li>In the “real world” we are limited by budget constraints, so we appoint a project manager and then mentor and coach … </li></ul><ul><li>Coaching, coaching, coaching : </li></ul><ul><li>Active interaction with project managers </li></ul><ul><li>Creating a “business-oriented” thinking process </li></ul><ul><li>Adhering to work-plan </li></ul>
  8. 9. Funding <ul><li>RBM incubator is owned and funded by the </li></ul><ul><li>Chairman of the RAD Group of Companies </li></ul><ul><li>The projects are funded by the Israeli </li></ul><ul><li>Government and matching-funds are </li></ul><ul><li>provided by the owner of RBM </li></ul><ul><li>Additional funding may be provided by </li></ul><ul><li>business angels before or upon entry, </li></ul><ul><li>and/or during the incubation period </li></ul><ul><li>Our companies seek VC or corporate </li></ul><ul><li>funding upon graduation and at-times </li></ul><ul><li>also during the incubation period </li></ul>RBM maintains an active role in the fundraising process
  9. 10. Task Oriented Management Team Idan Tamir, Ph.D. President & CEO Binah Baum, Ph.D. MBA Director, Business Dev Shoshi Keynan, Ph.D. Project Manager Drug development specialists RAD group of companies Medical device consultants project IP experts Clinical & regulatory experts
  10. 11. Handling The Maturing Company Building Value To The Next Level √ Demonstrating proof of concept – critical milestone √ Creating a strong IP position with freedom to operate √ Initiating regulatory procedures – what does the FDA look for? Initiating discussion with regulatory consultants √ Preparing succinct business plan for next investment round √ Creating a professional advisory board & appointing a medical director √ Initiating alliances with companies e.g. FP7 consortia √ Helping to secure follow-up financing / alliances with strategic partners
  11. 12. Weaknesses <ul><li>Is project funding sufficient for required tasks? </li></ul><ul><li>will the tight budget allow us to chose the “perfect” manager? </li></ul><ul><li>How well do Government financing programs adapt to changing needs? </li></ul><ul><li>Distance from global markets </li></ul><ul><li>Support & coaching to company management </li></ul><ul><li>Responsibility and accountability </li></ul><ul><li>Focus on value creation - always market oriented </li></ul><ul><ul><li>Work-plan within a limited budget </li></ul></ul><ul><ul><li>Achieving technological POC within these constraints </li></ul></ul><ul><ul><li>Determination, flexibility & success orientation </li></ul></ul>Strengths
  12. 13. <ul><li>Go Europe: </li></ul><ul><li>create alliances </li></ul><ul><li>Inclusion of our SMEs in FP7 consortia </li></ul><ul><li>Participation of incubator in FP7 consortia </li></ul><ul><li>Collaborations betw. our SMEs and clinical-centers </li></ul><ul><li>/SMEs in other European bioregions </li></ul><ul><li>Incubation of European pre-seed projects in RBM </li></ul>What do we need to do in order “to do better” ? Janez Potocˇnick, European Commissioner for science and research

×